Novartis' malaria drug approved for infants and newborns
TL;DR Summary
The first malaria treatment specifically approved for babies and very young children has been developed by Novartis and is expected to be rolled out in African countries soon, addressing a critical treatment gap and potentially saving many young lives, especially in regions with high malaria mortality rates.
- First malaria treatment for babies approved for use BBC
- Novartis gets approval for first malaria drug for babies and children Reuters
- Novartis wins approval for first malaria drug for newborns Financial Times
- First malaria treatment for babies and infants approved for use Sky News
- Swissmedic approves Novartis’ malaria medicine for babies Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
91%
538 → 47 words
Want the full story? Read the original article
Read on BBC